Institutional investors active with Invesco Dynamic Biotechnology & Genome ETF
/Invesco Dynamic Biotechnology & Genome ETF (PBE) Shares Bought by Stifel Financial Corp
Stifel Financial Corp boosted its holdings in Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) by 34.4% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 21,776 shares of the company’s stock after buying an additional 5,578 shares during the quarter. Stifel Financial Corp owned approximately 0.40% of Invesco Dynamic Biotechnology & Genome ETF worth $1,025,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in PBE. SG Americas Securities LLC acquired a new position in shares of Invesco Dynamic Biotechnology & Genome ETF in the third quarter worth about $452,000. Morgan Stanley boosted its holdings in shares of Invesco Dynamic Biotechnology & Genome ETF by 6.5% in the third quarter. Morgan Stanley now owns 153,962 shares of the company’s stock worth $9,153,000 after buying an additional 9,391 shares during the period. Carnegie Capital Asset Management LLC boosted its holdings in shares of Invesco Dynamic Biotechnology & Genome ETF by 10.7% in the third quarter. Carnegie Capital Asset Management LLC now owns 5,330 shares of the company’s stock worth $271,000 after buying an additional 515 shares during the period. B. Riley Financial Inc. boosted its holdings in shares of Invesco Dynamic Biotechnology & Genome ETF by 14.4% in the third quarter. B. Riley Financial Inc. now owns 6,982 shares of the company’s stock worth $415,000 after buying an additional 880 shares during the period. Finally, YHB Investment Advisors Inc. boosted its holdings in shares of Invesco Dynamic Biotechnology & Genome ETF by 19.0% in the fourth quarter. YHB Investment Advisors Inc. now owns 25,395 shares of the company’s stock worth $1,195,000 after buying an additional 4,050 shares during the period.
